UK Markets closed
NIKKEI 225
27,419.61 -47.00 (-0.17%) HANG SENG
20,049.64 +458.21 (+2.34%) CRUDE OIL
69.65 -1.25 (-1.76%) GOLD FUTURES
2,000.40 +50.80 (+2.61%) DOW
31,872.07 -158.04 (-0.49%) BTC-GBP
22,782.88 +417.26 (+1.87%)
Paratek Pharmaceuticals, Inc. (PRTK)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:20PM EDT. Market open.
| Previous close | 1.8050 |
| Open | 1.8300 |
| Bid | 1.7000 x 1000 |
| Ask | 1.7100 x 900 |
| Day's range | 1.6800 - 1.8300 |
| 52-week range | 1.2900 - 3.6500 |
| Volume | |
| Avg. volume | 496,277 |
| Market cap | 95.545M |
| Beta (5Y monthly) | 1.51 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.1850 |
| Earnings date | 02 May 2023 - 08 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 31 Oct 2014 |
| 1y target est | 17.50 |
- Zacks
Paratek Pharmaceuticals (PRTK) Reports Q4 Loss, Tops Revenue Estimates
Paratek (PRTK) delivered earnings and revenue surprises of -1,300% and 33.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) On The Verge Of Breaking Even
With the business potentially at an important milestone, we thought we'd take a closer look at Paratek Pharmaceuticals...
- Simply Wall St.
Individual investors account for 39% of Paratek Pharmaceuticals, Inc.'s (NASDAQ:PRTK) ownership, while institutions account for 38%
If you want to know who really controls Paratek Pharmaceuticals, Inc. ( NASDAQ:PRTK ), then you'll have to look at the...
© 2023 Yahoo. All rights reserved.
